In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
在其许多实施形式中,本发明提供了一种新型的
吡唑并[1,5-a]
嘧啶类化合物,作为细胞周期依赖性激酶的
抑制剂,以及制备这种化合物的方法,含有一种或多种这种化合物的药物组合物,制备含有一种或多种这种化合物的药物配方的方法,以及使用这种化合物或药物组合物治疗、预防、抑制或改善与CDKs相关的一种或多种疾病的方法。